Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective study.
Patel P, Macdonald JC, Boobalan J, Marsden M, Rizzi R, Zenon M, Ren J, Chu H, Cappelleri JC, Roychoudhury S, O'Brien J, Izaki-Lee K, Boyce D.
Patel P, et al. Among authors: macdonald jc.
Front Med (Lausanne). 2023 Nov 8;10:1275817. doi: 10.3389/fmed.2023.1275817. eCollection 2023.
Front Med (Lausanne). 2023.
PMID: 38020129
Free PMC article.